Document is current
Any future updates will be listed below
-
Authors
Singh, Virendra
Singh, Ranjeet
Goswami, Pooja
Manna, Partha Pratim
Basu Baul, Tushar S.
Mandal, Abhijit
Singh, Arvind Kumar
Koch, Biplob
-
Funding
Funding for this research was provided by:
Indian Council of Medical Research (5/13/36/2022/NCD-III)
Banaras Hindu University (R/Dev/D/IoE/Incentive/2021-22/32449)
- License Information
-
More Information
Article History
Received: 17 July 2024
Accepted: 7 February 2025
First Online: 12 February 2025
Declarations
:
: The authors declare no competing interests.
: In vivo experimental protocols were approved by Institutional Animal Ethical Committee, Institute of Science, Banaras Hindu University, Varanasi India (Approval no. BHU/DoZ/IAEC/2021–2022/013). All the in vivo experiments were performed according to guidelines of (CPCSEA) Committee for the Purpose of Control and Supervision of Experiments on Animals (Reg. No. 1802/Go/RE/S/15/CPCSEA). The methods were reported in accordance with ARRIVE guidelines.
: The study does not include any human subjects, samples or case studies; hence this statement is not applicable.
: All the authors are giving their consent to publish an original research article entitled “Influences of aqua-(2-formylbenzoato) triphenyltin(IV) on regression of hypoxic solid tumor through mitochondrial mediated pathway by inhibiting Hif-1 alpha” for publication in the Scientific Reports journal.
